Aclaris Therapeutics, Inc. (ACRS) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
640 LEE ROAD WAYNE, PA 19087 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 248,100 | 255,800 | 203,600 | 225,700 | 243,600 | 266,200 | 142,700 | ||
| Cash and cash equivalents | 61,653 | 68,264 | 36,342 | 27,349 | 53,602 | 113,447 | 35,267 | ||
| Short-term investments | 186,409 | 180,339 | 143,280 | 164,065 | 144,280 | 118,227 | 93,028 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | 38 | 7,197 | 23,978 | 34,286 | 45,718 | 34,526 | 14,405 | ||
| Receivables | 597 | 637 | 633 | 623 | 811 | 939 | 817 | ||
| Other undisclosed current assets | 7,876 | 2,917 | (13,352) | (21,291) | (38,629) | (25,878) | (9,016) | ||
| Total current assets: | 256,573 | 259,354 | 190,881 | 205,032 | 205,782 | 241,261 | 134,501 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,145 | 1,276 | 1,277 | 1,335 | 1,170 | 1,287 | 1,424 | ||
| Long-term investments and receivables | 7,221 | 23,955 | 34,242 | 45,735 | 34,503 | 14,362 | |||
| Long-term investments | 7,221 | 23,955 | 34,242 | 45,735 | 34,503 | 14,362 | |||
| Intangible assets, net (including goodwill) | 6,992 | 7,011 | 7,030 | 7,048 | 7,067 | 7,086 | 7,105 | ||
| Intangible assets, net (excluding goodwill) | 6,992 | 7,011 | 7,030 | 7,048 | 7,067 | 7,086 | 7,105 | ||
| Other noncurrent assets | 2,922 | 3,114 | 3,384 | 3,554 | 3,740 | 3,909 | 4,007 | ||
| Total noncurrent assets: | 11,059 | 18,622 | 35,646 | 46,179 | 57,712 | 46,785 | 26,898 | ||
| TOTAL ASSETS: | 267,632 | 277,976 | 226,527 | 251,211 | 263,494 | 288,046 | 161,399 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 16,821 | 13,274 | 13,808 | 20,036 | 14,972 | 11,175 | 10,891 | ||
| Accounts payable | 7,667 | 5,703 | 8,121 | 9,985 | 7,564 | 4,244 | 7,292 | ||
| Accrued liabilities | 9,154 | 7,571 | 5,687 | 10,051 | 7,408 | 6,931 | 3,599 | ||
| Disposal group, including discontinued operation | 2,202 | 2,202 | 2,202 | 2,202 | 2,198 | 3,094 | 2,989 | ||
| Other liabilities | 716 | 693 | 669 | 647 | 625 | ||||
| Other undisclosed current liabilities | 766 | 741 | |||||||
| Total current liabilities: | 19,789 | 16,217 | 16,726 | 22,931 | 17,839 | 14,916 | 14,505 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2,559 | 2,730 | |||||||
| Operating lease, liability | 2,559 | 2,730 | |||||||
| Liabilities, other than long-term debt | 28,005 | 26,007 | 29,602 | 30,939 | 29,074 | 28,584 | 23,908 | ||
| Deferred income tax liabilities | 367 | 367 | 367 | 367 | 367 | 367 | 367 | ||
| Other liabilities | 1,638 | 1,840 | 2,035 | 2,172 | 2,507 | 2,917 | 3,041 | ||
| Business combination, contingent consideration, liability | 26,000 | 23,800 | 27,200 | 28,400 | 26,200 | 25,300 | 20,500 | ||
| Other undisclosed noncurrent liabilities | 8,172 | 7,962 | |||||||
| Total noncurrent liabilities: | 28,005 | 26,007 | 29,602 | 30,939 | 29,074 | 39,315 | 34,600 | ||
| Total liabilities: | 47,794 | 42,224 | 46,328 | 53,870 | 46,913 | 54,231 | 49,105 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 219,838 | 235,752 | 180,199 | 197,341 | 216,581 | 233,815 | 112,294 | ||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Additional paid in capital | 875,982 | 871,805 | 795,366 | 792,971 | 789,186 | 785,455 | 645,730 | ||
| Accumulated other comprehensive loss | (1,465) | (1,326) | (972) | (224) | (3) | (184) | (140) | ||
| Accumulated deficit | (654,680) | (634,728) | (614,196) | (595,407) | (572,603) | (551,457) | (533,296) | ||
| Total stockholders' equity: | 219,838 | 235,752 | 180,199 | 197,341 | 216,581 | 233,815 | 112,294 | ||
| TOTAL LIABILITIES AND EQUITY: | 267,632 | 277,976 | 226,527 | 251,211 | 263,494 | 288,046 | 161,399 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 19,018 | 1,528 | 1,453 | 1,501 | 1,659 | 1,824 | 1,777 | |
| Cost of revenue | (923) | (1,068) | (1,155) | (1,149) | (1,099) | (1,263) | (1,202) | |
| Gross profit: | 18,095 | 460 | 298 | 352 | 560 | 561 | 575 | |
| Operating expenses | (29,469) | (24,854) | (20,405) | (21,045) | (19,955) | (13,767) | (12,665) | |
| Other undisclosed operating income (loss) | (9,500) | 3,400 | 1,200 | (2,200) | (900) | (4,800) | (16,439) | |
| Operating loss: | (20,874) | (20,994) | (18,907) | (22,893) | (20,295) | (18,006) | (28,529) | |
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 922 | 462 | 118 | 89 | (851) | (155) | (225) | |
| Loss from continuing operations before equity method investments, income taxes: | (19,952) | (20,532) | (18,789) | (22,804) | (21,146) | (18,161) | (28,754) | |
| Other undisclosed income from continuing operations before income taxes | 752 | |||||||
| Loss before gain (loss) on sale of properties: | (19,952) | (20,532) | (18,789) | (22,052) | (21,146) | (18,161) | (28,754) | |
| Other undisclosed net loss | (752) | |||||||
| Net loss available to common stockholders, diluted: | (19,952) | (20,532) | (18,789) | (22,804) | (21,146) | (18,161) | (28,754) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (19,952) | (20,532) | (18,789) | (22,804) | (21,146) | (18,161) | (28,754) | |
| Other comprehensive income (loss) | (139) | (354) | (748) | (221) | 181 | (44) | (46) | |
| Comprehensive loss, net of tax, attributable to parent: | (20,091) | (20,886) | (19,537) | (23,025) | (20,965) | (18,205) | (28,800) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.